跳至主要内容
临床试验/NCT06331338
NCT06331338招募中不适用

Research on the Effectiveness of Using Decision Cycle for Person-Centered Glycemic Management on Self-Care Behaviors in Outpatients With Type 2 Diabetes

National Taiwan University Hospital2 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2024年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
130
试验地点
2
主要终点
glycemic control (HbA1c)

研究概览

简要总结

Decision cycle for person-centered glycemic management is a new diabetes decision making .It is defined as a purposefully designed holistic care intervention .The goal is to improve the self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin levels and delaying the occurrence of complications.

详细描述

The "Decision Cycle for Person-Centered Glycemic management" jointly proposed by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) in 2018 , which develops treatment goals and plans based on the patient's personal preferences, values, and goals.

Participants will be divided into two groups(treatment group 、control group).Treatment group will accept the "Decision Cycle for Person-Centered Glycemic Management " .It is a person-centered diabetes decision making. Control group will accept the traditional diabetes self-management education. It content focuses more on teaching relevant knowledge and some skills.It is a educator-centered approach.

Baseline / pre-intervention test (after signing informed consent form) post-intervention test (after finishing intervention) Researchers will compare treatment group and control group to see if treatment group has better performance on self-care Behaviors and glycated hemoglobin levels .

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with type 2 diabetes by a physician.
  • Age: 18 years or above.
  • Glycated hemoglobin (HbA1c ) test value: 7.5-9.0 %
  • No diabetic oral medications, insulin and glucagon-like peptide-1 were replaced in the outpatient when the case was admitted.
  • No pregnancy during the study period.
  • After the researcher explains the purpose of the research, the research subjects agree to join this researcher.
  • Those who are conscious and able to take care of themselves.
  • There is no diagnostic certificate from the American Psychiatric Association's Diagnostic Manual of Mental Disorders, Fourth Edition (DSM-IV)of all mental illnesses.
  • Those who can communicate in Mandarin and Taiwanese.

排除标准

  • Patients diagnosed with type 1 diabetes by a physician.
  • Age: Under 18 years old.
  • Glycated hemoglobin test value: less than 7.5 % and greater than 9.0 %
  • Those who replaced oral diabetes medications, insulin and glucagon-like peptide- 1 at the outpatient at the time of admission.
  • Pregnancy during the study period.
  • Those who are unable to take care of themselves and express themselves.

结局指标

主要结局

glycemic control (HbA1c)

时间窗: Before the task and 3 months post intervention

The HbA1c level is a marker of the average blood glucose levels over a period of the last 2-3 months.

次要结局

  • Diabetes Self-Care Behavior Scale(Before the task and 3 months post intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验